Old Web
English
Sign In
Acemap
>
authorDetail
>
Kim Hurtado
Kim Hurtado
Merck & Co.
Medicine
Phases of clinical research
Adverse effect
Internal medicine
Immunogenicity
2
Papers
9
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV: a randomized phase 3 study.
2021
AIDS
Lerato Mohapi
Yvett Pinedo
Olayemi Osiyemi
Khuanchai Supparatpinyo
Winai Ratanasuwan
Jean Michel Molina
Ron Dagan
Gretchen M. Tamms
Tina M. Sterling
Ying Zhang
Alison Pedley
Jon Hartzel
Yanqing Kan
Kim Hurtado
Luwy Musey
Jakub K. Simon
Ulrike K. Buchwald
Show All
Source
Cite
Save
Citations (0)
A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants.
2020
Pediatric Infectious Disease Journal
Heather L. Platt
David Greenberg
Bruce Tapiero
Robert A. Clifford
Nicola P. Klein
D. Hurley
Tulin Shekar
Jianing Li
Kim Hurtado
Shu-Chih Su
Katrina M. Nolan
Camilo J. Acosta
Richard D. McFetridge
Kara Bickham
Luwy Musey
Show All
Source
Cite
Save
Citations (9)
1